Increased investment in research and development by leading market players for the development of cell culture products is likely to fuel growth in the global cell culture market over the forecast period. Inorganic methods such as acquisition by leading industry players are likely to fuel market expansion during the forecast period. Cell biology entails considerable research and development of novel therapeutics such as stem cell and gene therapies to give reliable findings, research equipment, reagents, and other goods must be of the highest quality. The cost of cell biology research has risen significantly as a result of the rising necessity to maintain high-quality standards (by the use of high-grade materials) and adhere to regulatory body norms. As a result, high costs are a stifling factor in the worldwide cell culture industry.
According to Coherent Market Insights, Global Cell Culture Market is estimated to be valued at US$ 19,198.0 million in 2022 and is expected to exhibit a CAGR of 7.2% during the forecast period (2022-2030).
Top Companies in the Cell Culture Industry:
Corning Incorporated
Corning Incorporated engages in the display technologies, optical communications, environmental technologies, specialty materials, and life sciences businesses worldwide. The company was founded in 1851 and is headquartered in Corning, New York.
Merck KGaA
MERCK Kommanditgesellschaft auf Aktien, a science and technology company in Germany. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, cardiovascular and metabolic diseases. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Sartorius AG
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
BioSpherix, Ltd.
Founded in 1982, BioSpherix, Ltd. has supplied cytocentric equipment and systems to a continuously growing customer base in academic, research, pharmaceutical and biotechnology organizations throughout the world. The Xvivo GMP System platform offers many benefits for cell and gene therapies as customers move life-changing discoveries to the clinic. In 2014, BioSpherix Medical®, located in Parish, NY, was established to accommodate the demand for a vast array of cell culture lab equipment for cell research and cell/gene therapies.
